Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse

Inflammation

Volumn 21, Issue 4, 1997, Pages 431-442

  Puigneró, Violant ^a   Queralt, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 FLUOROPHENYL) 2 [(4 METHYLSULFONYL)PHENYL]CYCLOPENTENE; 6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; 6 OXOPROSTAGLANDIN F1 ALPHA; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; FLOSULIDE; INDOMETACIN; LEUKOTRIENE B4; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; MALE; MOUSE; NEUTROPHIL; NONHUMAN; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION;

ACETYLGLUCOSAMINIDASE; ADMINISTRATION, TOPICAL; ANIMALS; ARACHIDONIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG ERUPTIONS; EICOSANOIDS; ISOENZYMES; MALE; MICE; MICE, INBRED STRAINS; PEROXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA;

EID: 0030984515     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027370504822     Document Type: Article

References (37)

1. SMITH, W. L. 1992. Prostanoid biosynthesis and mechanism of action. Am. J. Physiol. 263:F181-F191.
2. DE WITT, D. L., and W. L. SMITH. 1990. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Aca. Sci. U.S.A. 265:5192-5198.
3. KUJUBU, D. A., B. S. FLETCHER, B. C. VARNUM, R. W. LIM, and H. R. HERSCHMAN. 1991. TIS10, a phorbol ester tumor promoter inducible mRNA from swiss 3T3 cells, encodes a novel prostaglandin synthetase/cyclooxygenase homologue, J. Biol. Chem. 266:12866-12872.
4. FLETCHER, B. S., D. A. KUJUBU, D. M. PERRIN, and H. R. HERSCHMAN. 1992. Structure of the mitogen inducible TIS10 gene and demonstration that TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:4338-4344.
5. O'BANION, M. K., V. D. WINN, and D. A. YUNG. 1992. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 89:4888-4892.
6. LEE, S. H., E. SOYOOLA, P. CHANMMUGAM, S. HART, and W. SUN. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:25934-25938.
7. O'SULLIVAN, M. G., F. H. CHILTON, E. M. HUGGINS, and C. E. MCCALL. 1992. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J. Biol. Chem. 267:14547-14550.
8. O'SULLIVAN, M. G., E. M. HUGGINS, E. A. MEADE, D. L. DEWITT, and C. E. MCCALL. 1992. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem. Biophys. Res. Commun. 187:1123-1127.
9. HEMPEL, S. L., M. M. MONICK, and G. W. HUNNINGHAKE. 1994. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J. Clin. Invest. 93:391-396.
10. PATRIGNANI, P., M. R. PANANA, A. GRECO, O. FUSCO, C. NATOLI, S. IACCOBELLI, F. CIPOLLONE, A. GARCI, C. CRÉMINON, J. MACLOUF, and C. PATRONO. 1994. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J. Pharmacol. Exp. Ther. 271:1705-1712.
11. VANE, J. R. 1994. To a better aspirin. Nature 367:215-216.
12. WIESENBERG-BOETTCHER, I., A. SCHWEIZER, J. R. GREEN, K. MUELLER, F. MAERKI, and J. PFEILSCHIFTER. 1989. The pharmacological profile of CGP 28,238, a novel highly potent anti-inflammatory compound. Drugs Exptl. Clin. Res. 15:501-509.
13. CHAN, C. C., R. GORDON, C. BRIDEAU, I. W. RODGER, C. S. LI et al. 1994. In vivo pharmacology of L-745, 337: a novel non-steroidal anti-inflammatory agent (NSAID) with an ulcerogenic sparing effect in rat and monkey stomach [abstract]. Can. J. Physiol. Pharmacol. 72(suppl 1):266.
14. BOYCE, S., C. C. CHAN, R. GORDON, C. S. LI, I. W. RODGER, et al., 1994. L-745, 337: a selective inhibitor of cyclooxygenase-2 elicits antinocioception but not gastric ulceration in rats. Neuropharmacol. 33:1609-16011.
15. CHUNG, C. C., S. BOYCE, C. BRIDEAU, A. W. FORD-HUTCHINSON, R. GORDON, D. GUAY, R. G. HILL, C-C. LI, J. MANCINI, M. PENNETON, P. PRASIT, R. RASOGI, D. RIENDAU, P. ROY, P. TAGARI, P. VICKERS, E. WONG, and I. W. RODGER. 1995. Pharmacology of selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsleroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharmacol. Exp. Ther. 274:1531-1537.
16. ASLANIAN, R., N. I. CARRUTHERS, and J. J. KAMINSKI. 1994. Cyclooxygenase-2: a novel target for therapeutic intervention. Exp. Opin. Invest. Drugs 3:1323-1325.
17. SCHULTZ, J., and K. KAMINKER. 1962. Myeloperoxidase of the leucocyte of normal human blood I. Content and localization. Arch. Biochem. Biophys. 525:37-44.
18. BRADLEY, P. B., D. A. PRIBAT, R. O. CHRISTENSEN, and G. ROTHSTEIN. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
19. BAILEY, P., J. A. STURM, and B. LOPEZ-RAMOS. 1982. A biochemical study of the cotton-pellet granuloma in the rat. Biochem. Pharmacol. 31:1213-1218.
20. CHANG, J., R. P. CARLSON, L. O'NEIL-DAVIS, B. LAMB, R. N. SHARMA, and A. J. LEWIS. 1986. Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis. Inflammation 10:205-214.
21. OPAS, E. E., R. J. BONNEY, and J. L. HUMES. 1985. Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J. Inv. Dermatol. 84:253-256.
22. CARLSON, R. P., L. O'NEILL-DAVIS, J. CHANG, and A. J. LEWIS. 1985. Modulation of mouse ear edema by cyclooxygenase and lypoxygenase inhibitors and other pharmacological agents. Agents Actions 17:197-204.
23. YOUNG, J. M., J. A. SPIRES, C. D. BEDFORD, B. WAGNER, S. J. BALLRON, and L. M. DE YOUNG. 1984. The mouse ear inflammatory response to topical arachidonic acid. J. Invest. Dermatol. 82:367-371.
24. MARKS, F., G. FUSTERBERGER, and E. KOWAMTZKI. 1981. Prostaglandin E-mediated mitogenic stimulation and mouse epidermis in vivo by divalent cation ionophore A23187 and by tumor promotor 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 41:696-702.
25. FUSTENBERGER, G. and F. MARKS. 1982. Early prostaglandin E synthesis is an obligatory event in induction of cell proliferation in mouse epidermis in vivo by phorbol ester TPA. Biochem. Biophys. Res. Commun. 92:749-756.
26. MULLER-DECKER, K., K. SCHOLZ, F. MARKS, and G. FURSTENBERGER. 1995. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinogen 12:31-41.
27. LANGENBACH, R., S. G. MORHAM, H. F. TIANO, C. D. LOFTIN, and B. I. GHANAYEM. 1995. Prostaglandin synthase I gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483-492.
28. BUSTOS, G., M. L. FERRÁNDIZ, M. J. SAN MIGUEL, M. J. ALCARAZ. 1995. A study of the novel anti-inflammatory agent florifenine topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions. Naunyn-Schmiedelberg's Arch. Pharmacol. 351:298-304.
29. MORHAM, S. G., R. LANGENBACH, C. D. LOFTIN, H. F. TIANO, and N. VOULOUMANOS. 1995. Prostaglandin synthase 2 gene disruption causes several renal pathology in the mouse. Cell 83:473-482.
30. DINCHUK, J. E., D. B. CAR, R. J. FOCHT, J. J. JOHNSTON, B. D. JAFFE, M. B. COVINGTON, N. R. CONTELL, V. M. ENG, R. J. COLLINS, P. M. CZERNIAK, S. A. GORRY, and J. M. TRZASKOS. 1995. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406-409.
31. KLEIN, T. N., SING, R. M., J. PFEILSCHIFTER, and V. ULLRICH. 1994. Selective inhibition of cyclooxygenase 2. Biochem. Biophys. Res. Commun. 197:494-500.
32. LI, J., G. D. ANDERSON, E. G. BURTON, J. N. COGBURN, J. T. COLLINS, D. J. GARLAND, S. A. GREGORY, H-C. HUANG, P. C. ISACKSON, C. M. KOBOLDT, E. W. LONGUSCH, M. B. NORTON, W. E. PERKINS, E. J. REINHHARD, K. SEIBERG, A. M. VEENHUIZEN, Y. ZHANG, and D. B. REITZ. 1995. 1,2-diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. J. Chem. Med. 38:4570-4578.
33. MITCHELL, J. A., P. AKANRASEREENONT, C. THIEMERMAN, R. I. FLOWER, and J. R. VANE. 1994. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90:11693-11697.
34. SUMMERS, J. B. 1990. Inhibitors of leukotriene biosynthesis. DN&P 3:517-526.
35. BATTISTINI, B., R. BOTTING, and Y. S. BAKHLE. 1994. COX-1 and COX-2: toward the development of more selective NSAIDs. DN&P 7:501-512.
36. LAM, B. K., and K. F. AUSTEN. 1992. Leukotrienes: Biosynthesis, release and actions. In Inflammation: Basic Principles and Clinical Correlates. Gallin, J. I., I. M. Golstein and R. Snyderman editors. Raven Press, Ltd., New York, 1992, 139-147.
37. 4 receptor. J. Lipid Mediators Cell. Signalling 10:213-228.